PPT-Harmonisation et

optimisation des processus en nom de votre équipe Présentation des zones damélioration à léquipe de nom de votre équipe Date Présentateurs Plan de la présentation Comment avonsnous déterminé les zones damélioration. O Box 195 1211 Geneva 20 Switzerland Telephone 41 22 338 32 06 Telefax 41 22 338 32 30 adminichorg httpwwwichorg Final Concept Paper Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management dated 28 July 2014 Endors In September 2009 Universal Display Corp obtained an international registration designating the European Union for the word UniversalPHOLED for the following goods in Class 1 of the Nice Classi57375cation chemicals for use in the manufacture of orga ICH HARMONISED TRIPARTITE GUIDELINE STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7 Current Step 4 version dated 24 June 1993 This Guideline has been developed by the ulatory parties, REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE - 1 - Final Concept P aper M7 : Assessment and C ont rol of DNA R eactive ( M utagenic) I mpurities in P harmaceuticals to Limit P ARMONISED RIPARTITE UIDELINE UALITY ANAGEMENT Q9 Current Step 4 version dated 9 November 2005 This Guideline has been developed by tation by the regulatory parties, in accordance with the al draft Formations données . à l’ensemble des directions. Septembre-octobre . 2013. Cécile Lagoutte. Conseillère senior en développement organisationnel. Direction du soutien à la Transformation. Pour commencer. REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH H ARMONISED T RIPARTITE G UIDELINE E VALUATION A ND R ECOMMENDATION O F P HARMACOPOEIAL T EXTS F OR U SE I N T HE ICH R E Palvi. Shah and Becki Aquilina. 1. Overview. ONS Quality Goals and Harmonisation. The Harmonisation Vision and Strategy. Harmonisation Planning and Process. Benefits of Harmonisation. Issues and Considerations. ICH Bracketing and matrixinp: designs for stabil& testing of drug substances and drug prod-u& cx *$-T* Step 2 November 2000 This draft guidance, when fmlized, will represent the Food and Drug Admin POST. -HARMONISATION . – TAX EXCEPTIONALISM OR JURISPRUDENTIAL CONSISTENCY?. RITA DE LA FERIA. (CENTRE FOR BUSINESS TAXATION, OXFORD UNIVERSITY). DIMITRIOS DOUKAS. (SCHOOL OF LAW, QUEEN’S UNIVERSITY BELFAST). Séminaire sur les politiques pharmaceutiques Experts Francophones. 14-18 septembre 2015, OMS - Genève. Alexandre de LA VOLPILIERE . Pharmacien, Conseiller du Secrétaire Exécutif . HPPN/OCEAC. 1. Problèmes communs. Alexander Kühn. CEPT. Legal and Procedural Implementation. International Specifications & Agreements. Technical Regulatory. Aspects. Economic and . Competion. Aspects. Baseline for spectrum regulation: Harmonisation. WG NaN Activities in Harmonisation in Numbering. 5. th. WG NaN meeting. Stockholm, 21-22 November 2012. Jan Vannieuwenhuyse, Jukka Rakkolainen. NaN(2012)031rev1. See document NaN(2012)030rev1. 112. 116. Chairman of the Malta Medicines Authority. Medicines Authority. 203,Level 3,. Rue D’Argens,. Gzira,GZR 136. 8. Tel: ( 356) 2343 9000. Fax: ( 356) 2343 9161. Email: . anthony.serracino-inglott. @gov.mt.